The technical chart pattern of Abbott Laboratories stock suggests the beginning of a trend reversal over the medium term.
● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
● According to Refinitiv, the company's ESG score for its industry is good.
Strengths
● Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
● The group's high margin levels account for strong profits.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
● Historically, the company has been releasing figures that are above expectations.
Weaknesses
● With an expected P/E ratio at 30.48 and 26 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
● The company's enterprise value to sales, at 4.48 times its current sales, is high.
● The company appears highly valued given the size of its balance sheet.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.